Biomakers

About Biomakers

Biomakers is a precision medicine and oncology intelligence company dedicated to extending the lifespan of patients with advanced diseases. The company provides personalized treatment recommendations through comprehensive molecular testing, genetic diagnosis, and in-depth bioinformatics analysis. By integrating large-scale molecular diagnostics with longitudinal real-world clinical data and a diverse tumor biobank, Biomakers transforms raw genomic information into actionable therapeutic insights for healthcare professionals and pharmaceutical partners.

The company serves a dual market, partnering directly with physicians and patients for diagnostic testing, while also collaborating with global pharmaceutical companies for drug discovery and clinical trial optimization. Operating across Latin America and the United States, Biomakers generates revenue through its genomic testing services, biomarker analysis, bioinformatics platforms, and data-driven research collaborations. This unique business model positions the company as critical infrastructure for global precision oncology research and development.

Biomakers differentiates itself through its AI-native platform, which structures and harmonizes real-world clinical data from hospital electronic medical records to unlock complex biological signals. Key features of the company include:

Proprietary digital molecular testing platforms leveraging artificial intelligence.

A deeply annotated tumor biobank containing over 100,000 cases.

High-throughput genomic sequencing capabilities for blood and tissue biopsies.

Strategic partnerships with leading biopharma companies to accelerate targeted therapies.

An expert international logistics network ensuring rapid sample processing across Latin America.